Royalty Pharma stock forecast
Royalty Pharma (RPD) Stock Forecast & Price Target
RPD Analyst Ratings
RPD Stock 12 Month Forecast
Average Price Target
€63.88▲(2.50% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Geoff Meacham | Citi | €63.28→€70.51 | buy | 13.14%Upside | Reiterated | 11/05/26 | ||
| Terence Flynn | Morgan Stanley | €60.56→€67.79 | buy | 8.78%Upside | Assigned | 11/05/26 | ||
| Chris Schott | J.P. Morgan | €56.04→€66.89 | buy | 7.33%Upside | Reiterated | 11/04/26 | ||
| Jason Gerberry | Bank of America Securities | €56.95 | buy | -8.62%Downside | Reiterated | 10/09/26 | ||
| Ashwani Verma | UBS | €59.66 | buy | -4.27%Downside | Assigned | 09/08/26 | ||
| Michael Nedelcovych | TD Cowen | €58.76→€61.47 | buy | -1.37%Downside | Assigned | 09/08/26 | ||
| Asad Haider | Goldman Sachs | €53.33→€59.66 | buy | -4.27%Downside | Reiterated | 08/06/26 | ||
| Umer Raffat | Evercore ISI | ― | hold | ― | Reiterated | 02/12/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Geoff MeachamCiti | BuyReiterated€63.28→€70.51 | 11/05/26 | 13.14%Upside | ||
| Terence FlynnMorgan Stanley | BuyAssigned€60.56→€67.79 | 11/05/26 | 8.78%Upside | ||
| Chris SchottJ.P. Morgan | BuyReiterated€56.04→€66.89 | 11/04/26 | 7.33%Upside | ||
| Jason GerberryBank of America Securities | BuyReiterated€56.95 | 10/09/26 | -8.62%Downside | ||
| Ashwani VermaUBS | BuyAssigned€59.66 | 09/08/26 | -4.27%Downside | ||
| Michael NedelcovychTD Cowen | BuyAssigned€58.76→€61.47 | 09/08/26 | -1.37%Downside | ||
| Asad HaiderGoldman Sachs | BuyReiterated€53.33→€59.66 | 08/06/26 | -4.27%Downside | ||
| Umer RaffatEvercore ISI | HoldReiterated | 02/12/26 | ― |
Best Analysts Covering Royalty Pharma
Copying Geoff Meacham's trades and holding each position for 3 Months would result in 76.00% of your transactions generating a profit, with an average return of +5.75% per trade.
Copying Geoff Meacham's trades and holding each position for 1 Year would result in 72.00% of your transactions generating a profit, with an average return of +22.10% per trade.
Copying Geoff Meacham's trades and holding each position for 2 Years would result in 84.00% of your transactions generating a profit, with an average return of +51.73% per trade.
RPD Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 10 | 8 | 13 | 13 | 11 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 10 | 8 | 13 | 13 | 11 |
In the current month, RPD has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RPD average Analyst price target in the past 3 months is 63.88.
RPD Financial Forecast
RPD Earnings Forecast
Next quarter’s earnings estimate for RPD is EUR 1.40 with a range of EUR 1.33 to EUR 1.47. The previous quarter’s EPS was EUR 1.08. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
RPD Sales Forecast
Next quarter’s sales forecast for RPD is EUR 860.20M with a range of EUR 819.25M to EUR 883.69M. The previous quarter’s sales results were EUR 617.88M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

